---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264727037.md"
description: "Crinetics Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 financial results."
datetime: "2025-11-06T21:39:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264727037.md)
  - [en](https://longbridge.com/en/news/264727037.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264727037.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/264727037.md) | [繁體中文](https://longbridge.com/zh-HK/news/264727037.md)


# 

Crinetics Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q3 financial results.

### Related Stocks

- [Crinetics Pharmaceuticals, Inc. (CRNX.US)](https://longbridge.com/en/quote/CRNX.US.md)

## Related News & Research

- [Crinetics Highlights Breakout Year and Strong Endocrinology Pipeline](https://longbridge.com/en/news/272471987.md)
- [Early PALSONIFY Launch and Atumelnant Data Might Change The Case For Investing In Crinetics (CRNX)](https://longbridge.com/en/news/271678163.md)
- [Crinetics Pharmaceuticals Announces Public Offering of Common Stock](https://longbridge.com/en/news/271841501.md)
- [Crinetics Pharmaceuticals Grants Stock Options and RSUs to New Employees Under 2021 Inducement Plan](https://longbridge.com/en/news/272317951.md)
- [Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Recent Strong Share Price Momentum](https://longbridge.com/en/news/271962928.md)